Analyze Diet
BMC veterinary research2022; 18(1); 215; doi: 10.1186/s12917-022-03323-3

Effects of oral treatment with chondroitin sulfate and glucosamine in an experimental model of metacarpophalangeal osteoarthritis in horses.

Abstract: Combined chondroitin sulfate (CS) and glucosamine (GlcN) has been widely used in oral formulations to prevent and treat osteoarthritis. CS is effective for controlling pain in osteoarthritic patients, whereas GlcN can stimulate glycosaminoglycan synthesis, thus reducing extracellular matrix degradation. Although several studies have been published on this topic, the effectiveness of treatment with oral CS and GlcN remains uncertain. The objective of this study was to analyze the progression of experimentally induced osteoarthritis in horses and verify the effectiveness of an oral compound based on CS and GlcN to treat and/or modulate this disease. The study analyzed the metacarpophalangeal joint of the left thoracic limb of 16 horses divided into two groups, with eight horses treated with CS and GlcN in the treated group (GT) and eight untreated horses in the control group (GC). Chondral lesions were induced through arthroscopy, which was defined as time-point zero (T0). Physical, ultrasonographic, and radiographic examinations and synovial fluid biomarkers measurements were performed on days 0, 30, 60, 90, and 120. At the end of the experiment (T4), arthroscopy was performed again to macroscopically evaluate the joints and collect material for microscopic analysis. Results: Significant differences were observed between groups in some evaluated parameters, such as visual lameness assessment, synovial concentrations of prostaglandin E2, and ultrasound examination. However, the GT still presented slightly improved results for joint flexion angle, analysis of lameness using sensors, and histopathological analysis of chondral repair tissue, however, without the statistical significance (p>0.05). Conclusions: The treatment was considered effective in the clinical modulation of experimental osteoarthritis, with improvement of some parameters in the GT. However, this type of treatment may not be entirely effective to change the catabolic process in articular cartilage and the progressive induced chondral damage.
Publication Date: 2022-06-09 PubMed ID: 35681208PubMed Central: PMC9178899DOI: 10.1186/s12917-022-03323-3Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research study investigates the impact of oral administration of a combined chondroitin sulfate (CS) and glucosamine (GlcN) compound on experimentally induced osteoarthritis in horses.

Objective of the Study

  • The primary aim of this study was to track the progression of osteoarthritis that was artificially induced in horses and study the effectiveness of an oral treatment containing CS and GlcN in managing and/or modulating this condition.

Research Methodology

  • The researchers used the left thoracic limb’s metacarpophalangeal joint in 16 horses. The horses were divided into two groups of eight each – the treated group (GT), who were given the CS and GlcN treatment, and the control group (GC) who remained untreated.
  • The onset of artificially induced chondral lesions was defined as time-point zero (T0). The evaluation of parameters such as physical, ultrasonographic, and radiographic examinations and synovial fluid biomarker measurements happened on days 0, 30, 60, 90, and 120.
  • The experiment culminated by performing arthroscopy again to evaluate the joints and gather material for microscopic analysis.

Results

  • The treated and control groups showed significant differences in some parameters, including visual lameness assessment, levels of prostaglandin E2 in synovial concentrations, and ultrasound examination results.
  • Although the treated group showed marginally improved results for joint flexion angle, sensor-based lameness analysis, and histopathological examination of chondral repair tissue, these improvements did not achieve statistical significance (p>0.05).

Conclusion

  • The study concluded that this treatment effectively modulated clinical osteoarthritis, as seen by the enhanced parameters in the treated group.
  • However, it may not be sufficient to alter the catabolic process in articular cartilage or prevent the progression of induced chondral damage.

Cite This Article

APA
Yamada ALM, do Prado Vendruscolo C, Marsiglia MF, Sotelo EDP, Agreste FR, Seidel SRT, Fülber J, Baccarin RYA, da Silva LCLC. (2022). Effects of oral treatment with chondroitin sulfate and glucosamine in an experimental model of metacarpophalangeal osteoarthritis in horses. BMC Vet Res, 18(1), 215. https://doi.org/10.1186/s12917-022-03323-3

Publication

ISSN: 1746-6148
NlmUniqueID: 101249759
Country: England
Language: English
Volume: 18
Issue: 1
Pages: 215
PII: 215

Researcher Affiliations

Yamada, Ana Lucia Miluzzi
  • Department of Surgery, School of Veterinary Medicine and Animal Science, University of São Paulo, Av. Prof. Dr. Orlando Marques de Paiva, 87. Cidade Universitária, São Paulo, SP, CEP: 05508-270, Brazil. anamyamada@usp.br.
do Prado Vendruscolo, Cynthia
  • Department of Internal Medicine, School of Veterinary Medicine and Animal Science, University of São Paulo, Av. Prof. Dr. Orlando Marques de Paiva, 87. Cidade Universitária, São Paulo, SP, CEP: 05508-270, Brazil.
Marsiglia, Marília Ferrari
  • Department of Surgery, School of Veterinary Medicine and Animal Science, University of São Paulo, Av. Prof. Dr. Orlando Marques de Paiva, 87. Cidade Universitária, São Paulo, SP, CEP: 05508-270, Brazil.
Sotelo, Eric Danilo Pauls
  • Department of Internal Medicine, School of Veterinary Medicine and Animal Science, University of São Paulo, Av. Prof. Dr. Orlando Marques de Paiva, 87. Cidade Universitária, São Paulo, SP, CEP: 05508-270, Brazil.
Agreste, Fernanda Rodrigues
  • Department of Internal Medicine, School of Veterinary Medicine and Animal Science, University of São Paulo, Av. Prof. Dr. Orlando Marques de Paiva, 87. Cidade Universitária, São Paulo, SP, CEP: 05508-270, Brazil.
Seidel, Sarah Raphaela Torquato
  • Department of Internal Medicine, School of Veterinary Medicine and Animal Science, University of São Paulo, Av. Prof. Dr. Orlando Marques de Paiva, 87. Cidade Universitária, São Paulo, SP, CEP: 05508-270, Brazil.
Fülber, Joice
  • Department of Surgery, School of Veterinary Medicine and Animal Science, University of São Paulo, Av. Prof. Dr. Orlando Marques de Paiva, 87. Cidade Universitária, São Paulo, SP, CEP: 05508-270, Brazil.
Baccarin, Raquel Yvonne Arantes
  • Department of Internal Medicine, School of Veterinary Medicine and Animal Science, University of São Paulo, Av. Prof. Dr. Orlando Marques de Paiva, 87. Cidade Universitária, São Paulo, SP, CEP: 05508-270, Brazil.
da Silva, Luis Claudio Lopes Correia
  • Department of Surgery, School of Veterinary Medicine and Animal Science, University of São Paulo, Av. Prof. Dr. Orlando Marques de Paiva, 87. Cidade Universitária, São Paulo, SP, CEP: 05508-270, Brazil.

MeSH Terms

  • Animals
  • Cartilage, Articular / pathology
  • Chondroitin Sulfates / pharmacology
  • Chondroitin Sulfates / therapeutic use
  • Glucosamine / pharmacology
  • Glucosamine / therapeutic use
  • Horse Diseases / metabolism
  • Horses
  • Lameness, Animal / metabolism
  • Models, Theoretical
  • Osteoarthritis / drug therapy
  • Osteoarthritis / pathology
  • Osteoarthritis / veterinary
  • Synovial Fluid / metabolism

Grant Funding

  • 2017/07255-5 / Fundau00e7u00e3o de Amparo u00e0 Pesquisa do Estado de Su00e3o Paulo

Conflict of Interest Statement

The authors declare that they have no competing interests.

References

This article includes 30 references
  1. Monteiro SO, Bettencourt EV, Lepage OM. Biologic strategies for intra-articular treatment and cartilage repair.. J Equine Vet Sci 2015;35(3):175–190.
  2. Elmesiry AM, Seleim MA, Mansour AA, Hill DC. Pentosan polysulfate as a disease modifier of cartilage degeneration in experimental osteoarthritis.. J Arthritis 2016;5(199):2.
  3. McIlwraith CW, Frisbie DD, Kawcak CE. The horse as a model of naturally occurring osteoarthritis.. Bone Joint Res 2012 Nov;1(11):297-309.
  4. McIlwraith CW, Kawcak CE, Frisbie DD, Little CB, Clegg PD, Peffers MJ, Karsdal MA, Ekman S, Laverty S, Slayden RA, Sandell LJ, Lohmander LS, Kraus VB. Biomarkers for equine joint injury and osteoarthritis.. J Orthop Res 2018 Mar;36(3):823-831.
    pubmed: 28921609doi: 10.1002/jor.23738google scholar: lookup
  5. Te Moller N. Development of an equine carpal groove model to study early changes in osteoarthritis-a pilot study.. Osteoarthr Cartil 2018;26(1):S132–S133.
  6. Silva MM, Hagen SCF, do Prado Vendruscolo C, Baccarin RYA, Spagnolo JD, Yamada ALM. The correlation between score-based protocol for equine joint assessment and subsequent arthroscopic intervention outcomes.. Braz J Vet Res Animal Sci 2019;56(4):e158072.
  7. Watanabe H, Yamada Y, Kimata K. Roles of aggrecan, a large chondroitin sulfate proteoglycan, in cartilage structure and function.. J Biochem 1998 Oct;124(4):687-93.
  8. Artuzi FE, Puricelli E, Baraldi CE, Quevedo AS, Ponzoni D. Reduction of osteoarthritis severity in the temporomandibular joint of rabbits treated with chondroitin sulfate and glucosamine.. PLoS One 2020;15(4):e0231734.
  9. Baccarin RY, Machado TS, Lopes-Moraes AP, Vieira FA, Michelacci YM. Urinary glycosaminoglycans in horse osteoarthritis. Effects of chondroitin sulfate and glucosamine.. Res Vet Sci 2012 Aug;93(1):88-96.
    doi: 10.1016/j.rvsc.2011.08.009pubmed: 21925689google scholar: lookup
  10. Moreira JJ, Coelho JM, Machado TSL, Morais APL, Michelacci YM, Baccarin RYA. Oral glucosamine and chondroitin sulfate on synovial fluid biomarkers from osteoarthritic equine joints.. Ciênc Rural 2019;49(9):e20180247.
  11. Morita M, Yamada K, Date H, Hayakawa K, Sakurai H, Yamada H. Efficacy of Chondroitin Sulfate for Painful Knee Osteoarthritis: A One-Year, Randomized, Double-Blind, Multicenter Clinical Study in Japan.. Biol Pharm Bull 2018 Feb 1;41(2):163-171.
    doi: 10.1248/bpb.b17-00556pubmed: 29176264google scholar: lookup
  12. Bottegoni C, Muzzarelli RA, Giovannini F, Busilacchi A, Gigante A. Oral chondroprotection with nutraceuticals made of chondroitin sulphate plus glucosamine sulphate in osteoarthritis.. Carbohydr Polym 2014 Aug 30;109:126-38.
    doi: 10.1016/j.carbpol.2014.03.033pubmed: 24815409google scholar: lookup
  13. van de Water E, Oosterlinck M, Dumoulin M, Korthagen NM, van Weeren PR, van den Broek J, Everts H, Pille F, van Doorn DA. The preventive effects of two nutraceuticals on experimentally induced acute synovitis.. Equine Vet J 2017 Jul;49(4):532-538.
    doi: 10.1111/evj.12629pmc: PMC5484312pubmed: 27554764google scholar: lookup
  14. Murray RC, Walker VA, Tranquille CA, Spear J, Adams V. A randomized blinded crossover clinical trial to determine the effect of an oral joint supplement on equine limb kinematics, orthopedic, physiotherapy, and handler evaluation scores.. J Equine Vet Sci 2017;50:121–128.
  15. Naito K, Watari T, Furuhata A, Yomogida S, Sakamoto K, Kurosawa H, Kaneko K, Nagaoka I. Evaluation of the effect of glucosamine on an experimental rat osteoarthritis model.. Life Sci 2010 Mar 27;86(13-14):538-43.
    doi: 10.1016/j.lfs.2010.02.015pubmed: 20188111google scholar: lookup
  16. Leatherwood JL, Gehl KL, Coverdale JA, Arnold CE, Dabareiner RA, Walter KN, Lamprecht ED. Influence of oral glucosamine supplementation in young horses challenged with intra-articular lipopolysaccharide.. J Anim Sci 2016 Aug;94(8):3294-3302.
    doi: 10.2527/jas.2016-0343pubmed: 27695773google scholar: lookup
  17. Higler MH, Brommer H, L'Ami JJ, de Grauw JC, Nielen M, van Weeren PR, Laverty S, Barneveld A, Back W. The effects of three-month oral supplementation with a nutraceutical and exercise on the locomotor pattern of aged horses.. Equine Vet J 2014 Sep;46(5):611-7.
    doi: 10.1111/evj.12182pubmed: 24011144google scholar: lookup
  18. Yamada ALM, Pinheiro M, Marsiglia MF, Hagen SCF, Baccarin RYA, da Silva LCLC. Ultrasound and clinical findings in the metacarpophalangeal joint assessment of show jumping horses in training.. J Vet Sci 2020 May;21(3):e21.
    doi: 10.4142/jvs.2020.21.e21pmc: PMC7263911pubmed: 32476309google scholar: lookup
  19. McIlwraith CW, Frisbie DD, Kawcak CE, Fuller CJ, Hurtig M, Cruz A. The OARSI histopathology initiative - recommendations for histological assessments of osteoarthritis in the horse.. Osteoarthritis Cartilage 2010 Oct;18 Suppl 3:S93-105.
    doi: 10.1016/j.joca.2010.05.031pubmed: 20864027google scholar: lookup
  20. Colbath AC, Frisbie DD, Dow SW, Kisiday JD, McIlwraith CW, Goodrich LR. Equine models for the investigation of mesenchymal stem cell therapies in orthopaedic disease.. Oper Tech Sports Med 2017;25(1):41–49.
  21. Maninchedda U, Lepage OM, Gangl M, Hilairet S, Remandet B, Meot F, Penarier G, Segard E, Cortez P, Jorgensen C, Steinberg R. Development of an equine groove model to induce metacarpophalangeal osteoarthritis: a pilot study on 6 horses.. PLoS One 2015;10(2):e0115089.
  22. Frisbie DD, Ghivizzani SC, Robbins PD, Evans CH, McIlwraith CW. Treatment of experimental equine osteoarthritis by in vivo delivery of the equine interleukin-1 receptor antagonist gene.. Gene Ther 2002 Jan;9(1):12-20.
    doi: 10.1038/sj.gt.3301608pubmed: 11850718google scholar: lookup
  23. Frisbie DD, Kisiday JD, Kawcak CE, Werpy NM, McIlwraith CW. Evaluation of adipose-derived stromal vascular fraction or bone marrow-derived mesenchymal stem cells for treatment of osteoarthritis.. J Orthop Res 2009 Dec;27(12):1675-80.
    doi: 10.1002/jor.20933pubmed: 19544397google scholar: lookup
  24. Broeckx SY, Pille F, Buntinx S, Van Brantegem L, Duchateau L, Oosterlinck M, Chiers K, Bertone AL, Spaas JH, Martens AM. Evaluation of an osteochondral fragment-groove procedure for induction of metacarpophalangeal joint osteoarthritis in horses.. Am J Vet Res 2019 Mar;80(3):246-258.
    doi: 10.2460/ajvr.80.3.246pubmed: 30801207google scholar: lookup
  25. Martin MS, Van Sell S, Danter J. Glucosamine and chondroitin: an appropriate adjunct treatment of symptomatic osteoarthritis of the knee.. Orthop Nurs 2012 May-Jun;31(3):160-6.
    doi: 10.1097/NOR.0b013e3182558cf5pubmed: 22622608google scholar: lookup
  26. Meininger CJ, Kelly KA, Li H, Haynes TE, Wu G. Glucosamine inhibits inducible nitric oxide synthesis.. Biochem Biophys Res Commun 2000 Dec 9;279(1):234-9.
    doi: 10.1006/bbrc.2000.3912pubmed: 11112445google scholar: lookup
  27. Welch CA, Potter GD, Gibbs PG, Eller EM. Plasma concentration of glucosamine and chondroitin sulfate in horses after an oral dose.. J Equine Vet Sci 2012;32(1):60–64.
  28. Severino RM, Jorge PB, Martinelli MO, de Lima MV, Severino NR, Duarte Junior A. Analysis on the serum levels of the biomarker CTX-II in professional indoor soccer players over the course of one season.. Rev Bras Ortop 2015 May-Jun;50(3):331-5.
    doi: 10.1016/j.rbo.2014.06.004pmc: PMC4519574pubmed: 26229939google scholar: lookup
  29. IBM Corp. Released . IBM SPSS Statistics for Windows, Version 21.0. Armonk: IBM Corp; 2012.
  30. R CORE TEAM. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. 2017. https://www.R-project.org/. Accessed Feb 2021.

Citations

This article has been cited 2 times.
  1. Muñoz JA, Martins TDS, Garbossa PLM, Pimentel LBF, Barbalho CB, da Silva MM, de Arruda AF, Baraldi-Artoni SM, Araújo CSDS, Pereira ASC. Bone development of broiler chickens supplemented with chondroitin sulfate and manganese. Vet Anim Sci 2025 Sep;29:100485.
    doi: 10.1016/j.vas.2025.100485pubmed: 40747004google scholar: lookup
  2. Protity AT, Zhou S. Recent advancement of glucosamine and N-acetyl glucosamine production using microorganisms: A review. J Ind Microbiol Biotechnol 2024 Dec 31;52.
    doi: 10.1093/jimb/kuaf014pubmed: 40424515google scholar: lookup